Estco Medical Launches New Web Site for MacroGenics

Share Article

Estco Medical today announced the launch of a new web site for MacroGenics at http://www.macrogenics.com.

Estco Medical today announced the launch of a new web site for MacroGenics at http://www.macrogenics.com. Based in Rockville, Maryland, MacroGenics is a biotechnology company focused on the development of therapeutic antibodies to treat patients with cancer, autoimmune disorders, allergy, and infectious diseases and vaccines to prevent infections in healthy individuals. The new site serves to track the progress of MacroGenics’ product portfolio and proprietary technology platforms.

MacroGenics consulted Estco Medical to design a professional site and to develop an online information center that provides up-to-date content for biotech professionals, collaborators, researchers, investors, and potential employees. Estco created a graphic design and site structure that portrays the company’s product development strategy and powered the site with Medigent CMS to easily administer updates to the evolving content.

The information architecture was developed to provide primary background content and media relations as well as site specific sections about MacroGenics' product pipeline. Estco also developed an interactive illustration of MacroGenics’ Fc receptor technology for the site which can easily be incorporated for presentation purposes.

"The web site not only looks professional, but nicely depicts our product focus in a descriptive and informative manner. The seamless integration with Medigent CMS allows each department to manage their respective site areas to monitor and maintain corporate updates," said Michael Richman, Chief Operating Officer of MacroGenics.

About MacroGenics, Inc.

MacroGenics is a privately funded company focused on the development and manufacture of biotechnology products including immunotherapeutics for cancer, infectious diseases and autoimmune disorders. MacroGenics' core platform involves antibody Fc receptor-related technologies, which are employed to improve the ways cytotoxic antibody mediate cell killing for the treatment of cancers and to prevent autoantibody from triggering disease in autoimmunity. For more information, visit http://www.macrogenics.com.

About Estco Medical

Founded in Bethesda, MD in 1999, Estco Medical is the creator of the web-based Medigent® software suite, which aids pharmaceutical, medical device, biotech and other life science companies in launching and managing online marketing initiatives. GE Healthcare, Medtronic, Aspect Medical Systems, the Cleveland Clinic, and leading pharmaceutical and medical device manufacturers are among the life science companies using the Medigent software suite to better communicate, educate and validate processes through every part of a product marketing life cycle. The Medigent software suite includes components for content management, media and investor relations, product and clinical education, community development and outcomes and market research studies. For more information, visit http://www.estcomedical.com or call 301-657-9332.

Press Contact:

John Estafanous, President

Estco Medical

johne@estcomedical.com

301-657-9332 x23

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

John Estafanous
Visit website